Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BioNexus Gene Lab Corp. (BGLC)
USD1.68
+0.04 (+2.13%)
MY NASDAQ Industrials Industrial - Distribution
Address
Tower B, Vertical Business Suite 59200
Kuala Lumpur, MY
Kuala Lumpur, MY
CEO
Su-Leng Tan
Website
bionexusgenelab.com
IPO
2021-01-08
CIK 1737523 ISIN US0906283066
Description
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.68
+0.04 (+2.13%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
98.6K
Beta
2.19
Float Shares
1.30M
Free Float %
64.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.33% | +14.85% | +10.48% | -14.71% | -48.90% | -41.27% | -45.92% | -93.50% | -98.92% | -99.12% | -99.12% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.68
Quality scores
Altman Z-Score
-0.21
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Industrial - Distribution: +4.8%-21.9% Q1'26: -98.9% (vs Q1'25)
-
EPS growth Industrial - Distribution: +8.9%-78.9% Q1'26: +37.1% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Distribution: +12.0%-46.8% Q1'26: -647.9% (vs Q1'25)
-
EBIT margin Industrial - Distribution: +5.8%-39.9% Q1'26: -2,501.7% (vs Q1'25)
-
ROIC Industrial - Distribution: +7.4%-46.3% Q1'26: -52.6% (vs Q1'25)
-
Share dilution Industrial - Distribution: +0.0%+4.2% Q1'26: +34.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Distribution: 0.84×-0.06× Q1'26: -0.10× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-1.86M
OE per share TTM
-0.97
Owner's Yield
-33.10%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
16.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
2
Total invested
497.00
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
2
+1 vs prev Q
New positions
2
Closed positions
1
Increased
2
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | UBS GROUP AG | 231.00 +231.0 (+100.0%) | 495.00 +495.0 (+100.0%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD2.14 +0.0% | 4 qtrs — |
| 2 | WELLS FARGO & COMPANY/MN | 1.00 +1.0 (+100.0%) | 2.00 +2.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 +7.0% | 1 qtrs NEW |
| 3 | DRW SECURITIES, LLC | — -47.8K (-100.0%) | — -188.9K (-100.0%) | 0.00% -2.576 pp | 0.00% -0.005 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-19 | Yew Chak Hua | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-19 | Yeoh Sook Keng | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-19 | Yap Chee Keong | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-19 | Wong Yee Meng | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-19 | Teoh Boon Teong | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-19 | Liong Tai Tan | Director / Officer | — | D | Common Stock, no par value | 0 | 0.00 | — | 12,500,460 | — | ↗ |
| 2023-07-19 | Lin Chai Ping | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-19 | Leong Wei Li | Officer | — | D | Common Stock, no par value | 0 | 0.00 | — | 4,797,709 | — | ↗ |
| 2023-07-19 | Fong Yeat Min | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-19 | Fong Teng Fook | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-98.8K
Shares Outstanding
2.01M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Su-Leng Tan Lee Chief Executive Officer & Chief Operating Officer | 490.1K | 1.0K | — | — | — | — | 491.1K | 0.00% | ↗ |
| 2 | 2023 | Yeat Min Fong Former Chairman | 16.1K | — | 7.6K | — | — | — | 23.7K | 32.06% | ↗ |
| 3 | 2023 | Yee Meng Wong Former President | 16.1K | — | 7.6K | — | — | — | 23.7K | 32.06% | ↗ |
| 4 | 2023 | Sook Keng Yeoh Former Chief Executive Officer | 12.0K | — | 7.6K | — | — | — | 19.6K | 38.72% | ↗ |
| 5 | 2023 | Wei Li Leong Former Chief Financial Officer | 16.0K | — | — | — | — | 842.00 | 16.8K | 0.00% | ↗ |
| 6 | 2023 | Su-Leng Tan Lee Chief Executive Officer & Chief Operating Officer | 9.1K | — | — | — | — | — | 9.1K | 0.00% | ↗ |
| 7 | 2023 | Chi Yuen Leong Former Chief Executive Officer | 3.3K | — | — | — | — | — | 3.3K | 0.00% | ↗ |
| 8 | 2022 | Yeat Min Fong Former Chairman | 5.0K | — | 10.4K | — | — | — | 17.4K | 59.81% | ↗ |
| 9 | 2022 | Yee Meng Wong Former President | 5.0K | — | 10.4K | — | — | — | 15.4K | 67.57% | ↗ |
| 10 | 2022 | Sook Keng Yeoh Former Chief Executive Officer | 5.0K | — | 10.4K | — | — | — | 15.4K | 67.57% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Su-Leng Tan | Chief Executive Officer, President, Secretary & Director | 446.0K | male |
| Set Fui Chong | Chief Financial Officer | 42.3K | female |
| Kwan Wah Chan | Marketing Manager | — | male |
| Too Kam Tham | Managing Director | — | male |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BGLC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
